Iradimed Corp
(IRMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,934 | 1,846 | 6,304 | 4,596 | 2,196 |
| Depreciation Amortization | 673 | 387 | 1,105 | 845 | 830 |
| Income taxes - deferred | 36 | N/A | -144 | N/A | N/A |
| Accounts receivable | -1,683 | -1,140 | -447 | -1,467 | -215 |
| Accounts payable and accrued liabilities | 179 | 375 | 34 | 204 | -56 |
| Other Working Capital | -2,482 | -2,096 | -1,808 | -3,116 | -866 |
| Other Operating Activity | 2,489 | 1,293 | 2,333 | 2,771 | 1,216 |
| Operating Cash Flow | $3,146 | $665 | $7,376 | $3,834 | $3,106 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,050 | 650 | 1,781 | 606 | -88 |
| PPE Investments | -153 | -93 | -265 | -164 | -112 |
| Investing Cash Flow | $897 | $557 | $1,516 | $441 | $-200 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 500 | 457 | 1,239 | 1,235 | 235 |
| Other Financing Activity | -148 | -23 | -310 | -16 | -16 |
| Financing Cash Flow | $352 | $434 | $930 | $1,218 | $220 |
| Beginning Cash Position | 28,028 | 28,028 | 18,206 | 18,206 | 18,206 |
| End Cash Position | 32,422 | 29,685 | 28,028 | 23,699 | 21,331 |
| Net Cash Flow | $4,394 | $1,657 | $9,822 | $5,493 | $3,125 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,146 | 665 | 7,376 | 3,834 | 3,106 |
| Capital Expenditure | -153 | -93 | -265 | -164 | -112 |
| Free Cash Flow | 2,992 | 573 | 7,111 | 3,670 | 2,994 |